Stock KILITCH KILITCH DRUGS (INDIA) LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Kilitch Drugs (India) Limited

Equities

KILITCH

INE729D01010

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:47 15/05/2024 BST 		5-day change 1st Jan Change
346 INR +1.73% Intraday chart for Kilitch Drugs (India) Limited +4.37% -6.93%
02-26 Kilitch Drugs (India) Unit Bags Supply Contract from Ethiopia MT
02-23 Kilitch Drugs Limited Wins Tender Issued by the Federal Democratic Republic of Ethiopia Pharmaceutical Supply Service for Supply of Pharmaceuticals CI

Business Summary

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical formulations. The Company’s products include Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. Its Parenteral and Nasal Products has a range of products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostic, uterine stimulants, veterinary and other areas in the form of ampoules and vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. Its herbal products are useful for sore throat, prostate problems, and can be used as supplements for diabetes, obesity, libido and others. Its medical devices offer a C-Seal brand.

Number of employees: 153

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical
88.5 %
1,010 88.5 % 1,236 88.5 % +22.31%
Out of Maharashtra Sales
10.9 %
119 10.4 % 153 10.9 % +28.14%
Other
0.5 %
13 1.1 % 7 0.5 % -41.93%

Sales per region

INR in Million2022Weight2023Weight Delta
India
100.0 %
1,142 100.0 % 1,396 100.0 % +22.20%

Managers

Managers TitleAgeSince
Mukund Prataprai Mehta CEO
 Chief Executive Officer 70 11/05/92
Sunil Sureshji Jain DFI
 Director of Finance/CFO 40 28/02/21
Pushpa Nyoupane CMP
 Compliance Officer - 04/05/22

Members of the board

Members of the board TitleAgeSince
Mukund Prataprai Mehta CEO
 Chief Executive Officer 70 11/05/92
Bhavin Mukund Mehta BRD
 Director/Board Member 48 28/09/07
Hemang Jagdish Engineer BRD
 Director/Board Member 58 31/03/15
Mira Bhavin Mehta BRD
 Director/Board Member 45 29/09/14
Vasudev Krishna Murti BRD
 Director/Board Member 72 15/03/18
Venkita Subramanian Rajan BRD
 Director/Board Member 80 27/06/18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 16,082,319 3,811,091 ( 23.70 %) 0 23.70 %

Shareholders

NameEquities%Valuation
Kilitch Co. (Pharma) Ltd.
41.22 %
6,629,342 41.22 % 29 M ₹
Bhavin Mukund Mehta
20.92 %
3,364,184 20.92 % 15 M ₹
Mukund Prataprai Mehta
7.093 %
1,140,647 7.093 % 5 M ₹
Dipak Kanaylal Shah
3.109 %
500,000 3.109 % 2 M ₹
Government of India
1.454 %
233,816 1.454 % 1 M ₹

Company contact information

Kilitch Drugs (India) Ltd.

Ujagar Industrial Estate Waman Tukaram Patil Marg

400088, Mumbai

+91 22 6121 4100

http://www.kilitch.com
address Kilitch Drugs (India) Limited(KILITCH)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
KILITCH DRUGS (INDIA) LIMITED Stock Kilitch Drugs (India) Limited
-6.93% 65.5M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.37% 588B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 326B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.83% 239B
NOVARTIS AG Stock Novartis AG
+9.93% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.95% 200B
AMGEN INC. Stock Amgen Inc.
+10.77% 167B
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. KILITCH Stock
  4. Company Kilitch Drugs (India) Limited